TrialThe Journal of infectious diseases2025
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.
Kara W Chew et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.